Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Ocugen, Inc. - Common Stock
(NQ:
OCGN
)
1.625
+0.125 (+8.33%)
Streaming Delayed Price
Updated: 11:00 AM EDT, Jun 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ocugen, Inc. - Common Stock
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
36
37
Next >
Ocugen Shares Move Higher, Try To Recover A Key Technical Level
↗
December 21, 2021
Ocugen Inc. (NASDAQ:OCGN) shares are trading higher Tuesda...
Via
Benzinga
Ocugen Stock Is Down but Not Out
↗
December 21, 2021
Even as investors lose hope in its Covid-19 vaccine catalyst, it isn't quite 'game over' for OCGN stock. A possible volatile long-term play.
Via
InvestorPlace
Looking Into Ocugen Inc's Recent Short Interest
↗
December 21, 2021
Ocugen Inc's (NASDAQ:OCGN) short percent of float has fallen 14.6% since last its last report. The company recently reported that it has 46.93 million shares sold short, which is...
Via
Benzinga
CANF Stock Alert: The Liver Cancer News Catapulting Can-Fite BioPharma Shares Higher Today
↗
December 20, 2021
Can-Fite BioPharma (CANF) stock is rocketing higher on Monday thanks to new data from a Phase II clinical trial for liver cancer.
Via
InvestorPlace
OCGN Stock Alert: What Is Going on With Ocugen Today?
↗
December 20, 2021
OCGN stock has been on a turbulent ride this morning following updates from Ocugen's partner Bharat Biotech. Here's what to know.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
December 20, 2021
The weekend break is over and that means it's time to get back to work with the biggest pre-market stock movers for Monday!
Via
InvestorPlace
As Covaxin Catalyst Fades, Stay Away From Ocugen Stock
↗
December 15, 2021
It may be making progress with another candidate in its pipeline, but as it ceases to be a vaccine play, OCGN stock will head lower.
Via
InvestorPlace
OCGN Stock Moves Higher on New Vaccine Data. What to Know.
↗
December 15, 2021
Shares of OCGN stock are getting some relief today and moving higher on positive results for its vaccine candidate.
Via
InvestorPlace
25 Stocks Moving in Monday's Pre-Market Session
↗
December 20, 2021
Gainers Society Pass Incorporated (NASDAQ: SOPA) rose 68% to $5.59 in pre-market trading after the company reported addition to the Russell 2000 Index. Verso Corporation (NYSE:...
Via
Benzinga
Don’t Expect Digital World to Tumble From Its New Deal With Rumble
↗
December 20, 2021
Trump Media & Technology Group announced a partnership with Rumble. Hiring the Canadian firm probably won’t be what makes DWAC stock tumble.
Via
InvestorPlace
7 Meme Stocks to Sell Before They Lose Momentum
↗
December 17, 2021
Meme stocks run the gamut from senseless to sensible. These seven unfortunately fall in the former camp, so steer clear.
Via
InvestorPlace
Christmas Is a Time for Ocugen Shareholders to Give Thanks
↗
December 15, 2021
This time last year, Ocugen traded below 30 cents. Up 1,683% since, owners of OCGN stock ought to be grateful for their unexpected returns.
Via
InvestorPlace
What's Going On With Ocugen Stock Today
↗
December 14, 2021
Ocugen Inc. (NASDAQ:OCGN) shares are trading lower Tuesday...
Via
Benzinga
Nio Day 2022: 13 Things for Nio Stock Investors to Expect on Dec. 18
↗
December 15, 2021
Nio (NIO) Day is quickly approaching and there are loads of rumors about electric vehicle (EV) reveals that have investors excited today.
Via
InvestorPlace
EV Stocks Outlook for 2022: Why One Analyst Sees Investor Enthusiasm Cooling Next Year
↗
December 15, 2021
One analyst believes the outlook for electric vehicle (EV) stocks in 2022 won't offer the same support it has during the current year.
Via
InvestorPlace
Ocugen Partnered COVID-19 Vaccine Candidate Generates Immune Memory At Least 6 Months After Vaccination
↗
December 15, 2021
Ocugen Inc (NASDAQ: OCGN) announced that immune response data following two doses of Covaxin from a third-party study were published on the preprint server, ...
Via
Benzinga
How Worrisome Is Ocugen's Latest Bad News?
↗
December 11, 2021
Investors don't need to be too concerned about the FDA's clinical hold on a Covaxin study-- for now.
Via
The Motley Fool
How Are The Shorts Feeling About Ocugen Inc?
↗
December 10, 2021
What happened: Ocugen Inc's (NASDAQ:OCGN) short interest has fallen 14% since the last report. The company recently reported that it has 46 million shares sold short, which is...
Via
Benzinga
RNG Stock Alert: The COO News That RingCentral Investors Hanging Up Their Shares Today
↗
December 09, 2021
RingCentral (RNG) stock isn't doing so hot on Thursday with heavy trading after the company announced a change in leadership.
Via
InvestorPlace
Investor Fears About Covaxin Have Ocugen Shares on Sale
↗
December 09, 2021
OCGN stock at this point is either an inexpensive Covid-19 vaccine stock or an over-priced investigational gene therapy stock — or both.
Via
InvestorPlace
RENN Stock Alert: Why “Facebook of China” Renren Is Plunging Today
↗
December 09, 2021
Renren (RENN) stock is falling hard on Thursday following an update on a $300 million court case against the Facebook of China.
Via
InvestorPlace
Topics
Lawsuit
OCGN Stock Pops on Key FDA News. Here’s What to Know.
↗
December 09, 2021
Ocugen is slipping today even after promising news breaks related to its gene therapy program, OCU400. Where is OCGN stock heading?
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
December 09, 2021
Gainers Ensysce Biosciences (NASDAQ:ENSC) stock increased by 74.49% to $5.2 during Thursday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
2 Big Stock Bets That Are Insiders Are Buying Now
↗
December 06, 2021
Reddit users picked their favorite biotech stocks, and all of them have fallen this year. The insiders have a different buying strategy.
Via
InvestorPlace
Ocugen Investors Are Betting On a Horse Than Can’t Win the Race
↗
December 06, 2021
Don't go bottom-fishing with OCGN stock even if it's at an enticing support level
Via
InvestorPlace
Ocugen Looks Risky as Markets Tire Of Speculative Vaccine Plays
↗
November 30, 2021
The window of opportunity is closing for also-ran vaccine makers, which is why OCGN has become a very volatile stock in the vaccine space.
Via
InvestorPlace
Ocugen Stock Very Well May Have Bottomed Out Here
↗
November 30, 2021
I don’t know if InvestorPlace’s Larry Ramer is still short, but if he is, he’s made a few bucks with OCGN stock down in the past month.
Via
InvestorPlace
Vaccine Stocks Ask The Unthinkable: What Happens If Today's Covid Shots Fail?
↗
November 29, 2021
Smaller companies are working on next-generation approaches to Covid treatment.
Via
Investor's Business Daily
20 Stocks Moving in Monday's Pre-Market Session
↗
November 29, 2021
Gainers Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 85.6% to $3.88 in pre-market trading after jumping 14% on Friday. Petros Pharmaceuticals recently said Q3 sales results...
Via
Benzinga
56 Biggest Movers From Friday
↗
November 29, 2021
Gainers iSpecimen Inc. (NASDAQ: ISPC) climbed 71.7% to settle at $17.51 on Friday. The company recently announced it has been contracted to support new advanced research on...
Via
Benzinga
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
36
37
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.